Adaptive Biotechnologies

Adaptive Biotechnologies Corporation is a publicly traded immune medicine company specializing in immune system-related products for the...

Facts

HQ: Seattle
Sectors: Biotech, Immune medicine, Diagnostics
Founded: 2009 Seattle business license
Type: Corporation Seattle business license
Registered name: Adaptive Biotechnologies Corporation Seattle business license
Stage: Public

Leadership or executive-pay change Jul 29, 2026 SEC Form 8-K
Signed a material agreement Jun 22, 2026 SEC Form 8-K
Leadership or executive-pay change Apr 9, 2024 SEC Form 8-K
Leadership or executive-pay change Apr 2, 2024 SEC Form 8-K
Leadership or executive-pay change Sep 1, 2023 SEC Form 8-K
Leadership or executive-pay change Aug 2, 2023 SEC Form 8-K
Leadership or executive-pay change Jun 13, 2023 SEC Form 8-K
Leadership or executive-pay change Apr 11, 2023 SEC Form 8-K
Signed a material agreement Sep 12, 2022 SEC Form 8-K
Leadership or executive-pay change Mar 11, 2022 SEC Form 8-K
Layoff announced: 100 employees (12% of staff) Mar 8, 2022 geekwire.com Data: layoffs.fyi
Leadership or executive-pay change Feb 15, 2022 SEC Form 8-K
Leadership or executive-pay change Jan 10, 2022 SEC Form 8-K
Leadership or executive-pay change Nov 3, 2021 SEC Form 8-K
Leadership or executive-pay change Mar 17, 2021 SEC Form 8-K
Leadership or executive-pay change Mar 5, 2021 SEC Form 8-K
Leadership or executive-pay change Jan 27, 2021 SEC Form 8-K
Leadership or executive-pay change Oct 16, 2020 SEC Form 8-K
Signed a material agreement Jul 16, 2020 SEC Form 8-K
Leadership or executive-pay change Jun 26, 2020 SEC Form 8-K
Leadership or executive-pay change Feb 18, 2020 SEC Form 8-K